Please login to the form below

Not currently logged in
Email:
Password:

Nordics investigate vaccine narcolepsy link

Sweden and Finland have opened inquiries into whether the GSK swine flu vaccine Pandemrix is responsible for cases of narcolepsy in children

Läkemedelsverket, Sweden's Medical Products Agency (MPA), and Finland's National Institute for Health and Welfare (THL) have begun investigating if the GlaxoSmithKline (GSK) vaccine Pandemrix is responsible for cases of narcolepsy among children treated with the H1N1 "swine flu" drug. The investigations have been launched in response to physician reports.

The MPA has received six reports from healthcare professionals regarding narcolepsy as a suspected adverse drug reaction following Pandemrix flu vaccination," the Agency said in a statement.

These reports concern children aged 12-16 years who developed symptoms of narcolepsy within two months of inoculation with Pandemrix.

In Finland, the number of narcolepsy cases reported this year was 12-14, which is much higher than the average of three cases annually. This increase has prompted officials there to consider a link between the condition and either the vaccine or the flu itself. 

The Finnish cases were detected among children aged 5-15 years. Symptoms began between December and February, during the winter 2009/10 flu season, and the cases were diagnosed in early spring and summer.

Kerhi Kilpi, the director of THL's vaccine department, has said that she does not believe a link exists but that any doubts must be examined.

Preliminary results from the investigations are expected by the end of the year.

19th August 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...